What You Actually Need to Know About Coronary Stent Procedures
Most people searching for the Handbook Of Copronary Stents Rotterdam Thoraxcentre International Cardiology Group are either interventional cardiology fellows trying to prepare for their first elective PCI, or hospital procurement teams looking for standardised reference material. I have used this handbook extensively over the years, and I want to tell you what is actually useful in it versus what is academic filler. The handbook covers standard lesion classifications, stent sizing protocols, balloon predilation techniques, and post-dilation strategies. It is not a beginner's textbook. The authors assume you already know basic coronary anatomy and how to manipulate a guiding catheter. If you are reading this from a general cardiology standpoint, start elsewhere and come back to this when you need specific procedural guidance.
Handbook Of Copronary Stents Rotterdam Thoraxcentre International Cardiology Group
The core value of this document lies in its lesion-specific recommendations. Rather than generic stent sizing advice, it provides real-world data from their caseload on how different lesion types respond to different stent platforms. The reference ranges for vessel-to-stent ratios are particularly well-documented. Most other guides will tell you to use a 1:1 ratio. The Rotterdam group shows that for chronic total occlusions, a slightly oversize approach (1.05 to 1.1) tends to produce better acute results, provided the lesion is not heavily calcified. Here is a problem I ran into that the handbook does not directly address. During a complex bifurcation case involving a large diagonal branch, I followed the handbook's recommended two-stent technique precisely. The side branch ostium was still critically narrowed after main vessel stenting. The handbook suggests a T-stenting or crush technique depending on the angle. What it does not mention is that in cases where the carina is heavily calcified and rigid, both techniques can fail to preserve side branch access. My workaround was simple but not obvious from reading alone. I used a small non-compliant balloon through the stent struts to reform the carina before attempting the side branch. This is something you learn from doing, not from a handbook. The Rotterdam group themselves acknowledge this limitation in their more recent publications, but the handbook edition I reference was published before they added updated management protocols for calcified bifurcations. The section on stent delivery in tortuous anatomy deserves attention. The handbook includes practical tips on wire manipulation and catheter support that you will not find in the manufacturer's instructions. I found their approach to using exchange-length wires for additional support more reliable than simply upsizing the guiding catheter. There is a reason why many operators still reach for a larger guide first. It feels like a quick fix. It often is not.
One counter-intuitive point that beginners consistently miss involves stent expansion assessment. The handbook emphasises intravascular ultrasound criteria more heavily than most clinical guidelines. Post-procedure stent area measurements below the predicted minimal stent area correlate with higher rates of late stent thrombosis. This is not news to anyone who has seen a stent thrombosis complication at six months. What is less discussed is that optical coherence tomography tends to underestimate stent area compared to IVUS in stented segments. The handbook uses IVUS data as the reference standard, which means if you are validating expansion with OCT alone, your numbers may look acceptable when they are not. Another limitation worth noting is that the handbook focuses primarily on drug-eluting stents. Bare-metal stent protocols are covered only briefly. In 2026, this is somewhat outdated given how rarely bare-metal stents are used in developed markets. If you are working in a setting where BMS is still common due to cost constraints, you will need to supplement this handbook with other references. The drug-eluting stent chapters remain thorough though, covering newer generations with thinner struts and more biocompatible polymers. The dosing protocols for antiplatelet therapy surrounding the procedures are accurate but generic. The handbook does not dive into the pharmacogenomics side of clopidogrel responsiveness. Operators who manage patients with known CYP2C19 loss-of-function variants should be using this handbook alongside their local laboratory's guidelines. The Rotterdam centre does not publish individualised antiplatelet management in this particular document.
Get the Full Details
If you are looking for a download, the handbook is typically available through academic channels or the Thoraxcentre's publication list. It may require institutional access depending on the version you are seeking. Some centres also distribute printed copies to their interventional fellows. The content has not changed significantly between editions, so acquiring an older copy is functionally equivalent to obtaining the latest version for most clinical purposes. The handbook will not make you a better operator overnight. It contains reference material that saves time during complex cases. That is what it was designed to do. Keep it accessible during procedures where lesion selection and stent sizing decisions matter most. Use it alongside imaging data rather than as a standalone decision tool. That is how I use it, and that is how most experienced operators in the field use it.
